FDA approves wider marketing for Enbrel

06/2/2005 | MSN Money

Amgen and Wyeth Pharmaceuticals reported the FDA approved expanded marketing for Enbrel to treat arthritis associated with psoriasis. The decision allows the companies to market Enbrel for improvement of physical function in patients with psoriatic arthritis in addition to the previously approved treatment for signs and conditions of the disease.

View Full Article in:

MSN Money

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA